PACK Private Wealth’s Royalty Pharma RPRX Stock Holding History

PACK Private Wealth’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$976K	Hold	17,414	–	–	0.4%	22
2026 Q1	$835K	Hold	17,414	–	–	0.38%	21
2025 Q4	$673K	Hold	17,414	–	–	0.31%	23
2025 Q3	$614K	Hold	17,414	–	–	0.29%	26
2025 Q2	$627K	Hold	17,414	–	–	0.33%	17
2025 Q1	$542K	Hold	17,414	–	–	0.32%	21
2024 Q4	$444K	Hold	17,414	–	–	0.26%	26
2024 Q3	$493K	Hold	17,414	–	–	0.28%	23
2024 Q2	$459K	Hold	17,414	–	–	0.29%	22
2024 Q1	$529K	Hold	17,414	–	–	0.33%	18
2023 Q4	$489K	Hold	17,414	–	–	0.33%	20
2023 Q3	$467K	Hold	17,414	–	–	0.35%	20
2023 Q2	$535K	Buy	+17,414	New	+$590K	0.4%	18
2023 Q1	–	Sell	-17,414	Closed	-$688K	–	37
2022 Q4	$688K	Hold	17,414	–	–	0.59%	18
2022 Q3	$700K	Hold	17,414	–	–	0.66%	18
2022 Q2	$732K	Hold	17,414	–	–	0.67%	16
2022 Q1	$678K	Buy	17,414 +5,472	+46%	+$215K	0.56%	16
2021 Q4	$476K	Buy	+11,942	New	+$464K	0.38%	21

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PACK Private Wealth's RPRX Position: Q2 2026 in Review

PACK Private Wealth held its Royalty Pharma (RPRX) position steady in Q2 2026 at 17,414 shares worth $976K. The position accounts for 0.4% of the portfolio, ranked #22.

PACK Private Wealth first reported a position in RPRX in Q4 2021 and has held it in 18 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

PACK Private Wealth held 17,414 shares of Royalty Pharma worth $976K as of Q2 2026.
PACK Private Wealth left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up 0.4% of PACK Private Wealth's portfolio in Q2 2026, its #22 holding.
PACK Private Wealth first reported a position in Royalty Pharma in Q4 2021 and has held it in 18 quarters since.
646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on PACK Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.